These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 11137881

  • 1. Beta-amyloid (1-42) affects MTT reduction in astrocytes: implications for vesicular trafficking and cell functionality.
    Kerokoski P, Soininen H, Pirttilä T.
    Neurochem Int; 2001 Feb; 38(2):127-34. PubMed ID: 11137881
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Amyloid beta-peptide alters the distribution of early endosomes and inhibits phosphorylation of Akt in the presence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT).
    Kubo T, Nishimura S, Oda T.
    Brain Res Mol Brain Res; 2002 Oct 15; 106(1-2):94-100. PubMed ID: 12393269
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibitors of V-type ATPases, bafilomycin A1 and concanamycin A, protect against beta-amyloid-mediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction.
    Kane MD, Schwarz RD, St Pierre L, Watson MD, Emmerling MR, Boxer PA, Walker GK.
    J Neurochem; 1999 May 15; 72(5):1939-47. PubMed ID: 10217271
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides.
    Shearman MS, Hawtin SR, Tailor VJ.
    J Neurochem; 1995 Jul 15; 65(1):218-27. PubMed ID: 7790863
    [Abstract] [Full Text] [Related]

  • 8. Amyloid beta-peptide-induced inhibition of MTT reduction in PC12h and C1300 neuroblastoma cells: effect of nitroprusside.
    Takenouchi T, Munekata E.
    Peptides; 1998 Jul 15; 19(2):365-72. PubMed ID: 9493870
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis.
    Liu Y, Schubert D.
    J Neurochem; 1997 Dec 15; 69(6):2285-93. PubMed ID: 9375659
    [Abstract] [Full Text] [Related]

  • 10. Both oxidative stress-dependent and independent effects of amyloid beta protein are detected by 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction assay.
    Abe K, Saito H.
    Brain Res; 1999 May 29; 830(1):146-54. PubMed ID: 10350568
    [Abstract] [Full Text] [Related]

  • 11. Cellular MTT reduction distinguishes the mechanism of action of beta-amyloid from that of tachykinin receptor peptides.
    Shearman MS.
    Neuropeptides; 1996 Apr 29; 30(2):125-32. PubMed ID: 8771554
    [Abstract] [Full Text] [Related]

  • 12. Substrate-dependence of reduction of MTT: a tetrazolium dye differs in cultured astroglia and neurons.
    Takahashi S, Abe T, Gotoh J, Fukuuchi Y.
    Neurochem Int; 2002 Apr 29; 40(5):441-8. PubMed ID: 11821152
    [Abstract] [Full Text] [Related]

  • 13. Beta-amyloid-induced cell toxicity: enhancement of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-dependent cell death.
    Hertel C, Hauser N, Schubenel R, Seilheimer B, Kemp JA.
    J Neurochem; 1996 Jul 29; 67(1):272-6. PubMed ID: 8667002
    [Abstract] [Full Text] [Related]

  • 14. Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT.
    Abe K, Matsuki N.
    Neurosci Res; 2000 Dec 29; 38(4):325-9. PubMed ID: 11164558
    [Abstract] [Full Text] [Related]

  • 15. Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures.
    Harris ME, Wang Y, Pedigo NW, Hensley K, Butterfield DA, Carney JM.
    J Neurochem; 1996 Jul 29; 67(1):277-86. PubMed ID: 8667003
    [Abstract] [Full Text] [Related]

  • 16. The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide(25-35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease.
    Subramaniam R, Koppal T, Green M, Yatin S, Jordan B, Drake J, Butterfield DA.
    Neurochem Res; 1998 Nov 29; 23(11):1403-10. PubMed ID: 9814551
    [Abstract] [Full Text] [Related]

  • 17. Endocytosis and Transcytosis of Amyloid-β Peptides by Astrocytes: A Possible Mechanism for Amyloid-β Clearance in Alzheimer's Disease.
    Domínguez-Prieto M, Velasco A, Tabernero A, Medina JM.
    J Alzheimers Dis; 2018 Nov 29; 65(4):1109-1124. PubMed ID: 30103329
    [Abstract] [Full Text] [Related]

  • 18. Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death.
    Wogulis M, Wright S, Cunningham D, Chilcote T, Powell K, Rydel RE.
    J Neurosci; 2005 Feb 02; 25(5):1071-80. PubMed ID: 15689542
    [Abstract] [Full Text] [Related]

  • 19. Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells.
    Pollack SJ, Sadler II, Hawtin SR, Tailor VJ, Shearman MS.
    Neurosci Lett; 1995 Jan 23; 184(2):113-6. PubMed ID: 7724043
    [Abstract] [Full Text] [Related]

  • 20. Abeta mediated diminution of MTT reduction--an artefact of single cell culture?
    Rönicke R, Klemm A, Meinhardt J, Schröder UH, Fändrich M, Reymann KG.
    PLoS One; 2008 Sep 18; 3(9):e3236. PubMed ID: 18800168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.